Related Experiment Video
Updated: Jun 5, 2026
A Method to Quantify Visual Information Processing in Children Using Eye Tracking
Published on: July 9, 2016
Reliability of eye tracking and pupillometry measures in individuals with fragile X syndrome
Faraz Farzin1, Felicia Scaggs, Crystal Hervey
1Department of Psychology, Stanford University, 450 Serra Mall, Stanford, CA 94305, USA. ffarzin@stanford.edu
Abstract:
Recent insight into the underlying molecular and cellular mechanisms of fragile X syndrome (FXS) has led to the proposal and development of new pharmaceutical treatment strategies, and the initiation of clinical trials aimed at correcting core symptoms of the developmental disorder. Consequently, there is an urgent and critical need for outcome measures that are valid for quantifying specific symptoms of FXS and that are consistent across time. We used eye tracking to evaluate test-retest reliability of gaze and pupillometry measures in individuals with FXS and we demonstrate that these measures are viable options for assessing treatment-specific outcomes related to a core behavioral feature of the disorder.
Insights
Eye tracking measures like gaze and pupillometry show reliable results in individuals with fragile X syndrome (FXS). These methods can effectively assess treatment outcomes for core behavioral features of FXS.
Area of Science:
- Neurodevelopmental disorders
- Genetics and molecular biology
Background:
- Fragile X syndrome (FXS) is a leading genetic cause of developmental delay and intellectual disability.
- Emerging research into FXS molecular mechanisms is driving new therapeutic strategies and clinical trials.
- Validated outcome measures are crucial for evaluating treatment efficacy in FXS clinical trials.
Purpose of the Study:
- To assess the test-retest reliability of eye tracking measures (gaze and pupillometry) in individuals with FXS.
- To determine the viability of these eye tracking measures as outcome assessments for FXS clinical trials.
Main Methods:
- Utilized eye tracking technology to collect gaze and pupillometry data.
- Evaluated data for test-retest reliability in a cohort of individuals diagnosed with FXS.
Main Results:
- Demonstrated significant test-retest reliability for both gaze and pupillometry measures in the FXS cohort.
- Eye tracking metrics proved consistent across repeated assessments, indicating stability.
Conclusions:
- Eye tracking, specifically gaze and pupillometry, offers a reliable and valid method for quantifying FXS behavioral symptoms.
- These validated measures can serve as sensitive outcome assessments in clinical trials targeting FXS treatments.
